Cleared Traditional

K132062 - ESIE APPS SUITE

K132062 is the FDA 510(k) clearance for ESIE APPS SUITE by Siemens Medical Solutions USA, Inc.. It is a Class 2 Radiology device (product code LLZ) cleared through the Traditional 510(k) pathway after a 20-day FDA review.

K132062 · Siemens Medical Solutions USA, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2013
Decision
20d
Days
Class 2
Risk

K132062 is an FDA 510(k) clearance for the ESIE APPS SUITE. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Siemens Medical Solutions USA, Inc. (Moutain View, US). The FDA issued a Cleared decision on July 23, 2013 after a review of 20 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Siemens Medical Solutions USA, Inc. devices

Submission Details

510(k) Number K132062 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 03, 2013
Decision Date July 23, 2013
Days to Decision 20 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
87d faster than avg
Panel avg: 107d · This submission: 20d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Regulatory Technology Services, LLC
MARK JOB

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1093
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K132062.
SYNGO.MR GENERAL
K130749 · Siemens Medical Solutions USA, Inc. · Aug 2013
QLAB QUANTIFICATION SOFTWARE
K132165 · Philips Ultrasound, Inc. · Aug 2013
ULTRAEXTEND USWS-900A V2.1 AND V3.1
K131822 · Toshiba America Medical Systems, In.C · Jul 2013
CODIAGNOSTIX IMPLANT PLANNING SOFTWARE
K130724 · Straumann USA · Jun 2013
SYNAPSE 3D LUNG AND ABDOMEN ANALYSIS
K130542 · Fujifilm Medical System U.S.A., Inc. · Jun 2013
MR PERMEABILITY
K130278 · Philips Medical Systems Nederland B.V. · May 2013